STOCKS TELEGRAPH

Tag: Mid day movers

Tesla Inc. (NASDAQ: TSLA) Reportedly Discuss Nickel Supply Deal With Top Miner BHP

Tesla Inc. (NASDAQ: TSLA) is in discussion with Top Miner BHP Group Limited (NYSE: BHP) over the nickel supply deal. The electric car maker is trying to secure the nickel supply for future use as the company expects to grow the deliveries in the coming months. CEO Elon Musk has asked nickel miner to speed up the mining operations. The electric-car maker will need more nickel if it is planning for the new 4680 battery. Tesla will be using nickel in high performance and long-lasting batteries for electric vehicles.

The report disclosed that Tesla is in talks with BHP Group but the deal is not finalized yet as both the companies are currently negotiating the pricing terms. Nickel is the main component of the cathodes of EV batteries. Tesla is trying to increase the amount of metal used in vehicles to improve its performance.

If this deal will be finalized it would be a surprise for some of the investors of BHP as the nickel makes up a small part of the business of BHP. If Tesla will secure this deal, it means BHP is also trying to expand to its nickel mining capabilities.

Tesla Inc. (NASDAQ: TSLA) shares were trading down -2.75%% at $413.98 at the time of writing on Wednesday. Tesla Inc. (NASDAQ: TSLA) share price went from a low point around $45.71 to briefly over $502.49 in the past 52 weeks. It has moved up 805.67% from its 52-weeks low and moved down -17.61% from its 52-weeks high. TSLA market cap has remained high, hitting $416.48 billion at the time of writing.

On the other side, BHP Group shares went down 3.20% to $50.50 during the trading session on Tuesday. In the past 52-weeks of trading, this company’s stock has fluctuated between the low range of $29.78 and a high range of $58.35. It has moved up 69.58% from its 52-weeks low and moved down -13.46% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 1.40. This company has a market capitalization of $119.18 billion.

October 7, 2020
Stocks to Watch for Quick Gains This Week

The markets are doing well today, but there are stocks that are doing extraordinarily better than the rest of the market. By following market momentum, one can make good money with these stocks today. Some of the stocks that are gaining incredible momentum this afternoon are as below:

Oxbridge Re Holdings Ltd [NASDAQ: OXBR]

This is one of the stocks that have benefited immensely from the increased bullish sentiment in the equity markets. The stock has seen a massive increase in buying sentiment, and short volumes are on a decline. If this trend continues, OXBR could test $6 today, or within the week.

It is one of the stock’s that offers investors an opportunity for huge gains this week. So far, it’s up by over 200%, and anyone who got in earlier in the day is in big gains. Since there is no news, the move is purely speculative, and investors need to keep an eye on short action. As long as short volumes remain low, upside momentum is likely to remain dominant.

Virgin Galactic Holdings Inc [NYSE: SPCE]

This is another big mover this afternoon and looks set for more gains all through the day and possibly through the week. While there is no specific news about it, this stock, is riding on sentiment by Bank of America analysts that it could double in value. The analysts are counting on the fact that it has a unique market, and that it is well prepared to tackle the needs of this market.

The analysts have argued that while the business has not yet commenced operations, its potential growth in the space market is limitless. This validation has seen investor interest in this stock grow. As excitement around this stock grows, shorts could decline and see its value rally to new highs within the week. It’s an interesting stock to watch for investors chasing massive gains in a short time.

Uber [NYSE: UBER]

Uber is another interesting stock to watch today, and all through the week. While the stock has not yet pumped, there is potential that it could start recording massive gains. This follows news that the company had been given the green light to continue operating in London.

London is one of the largest markets for cab-hailing services and being denied the license was a huge blow to the company. As this news filters into the market, the stock is likely to record major gains short-term.

September 29, 2020
SG Blocks Inc [SGBX] Rallies after LAX COVID-19 Test Centers Deal

SG Blocks Inc [NASDAQ: SGBX] is quite strong this Friday and is up by over 40% at the time of writing. This follows the company’s announcement that it was planning to build a modular COVID-19 testing centre for LAX. The company expects to have it done by the 1^stof November 2020. The company stated that the test pods will include CLIA certified labs, and will also have the OSANG GeneFinder™ test that will allow it to give clients results in under 2 hours.

The company further stated that the tests would be made with a partnership with Grimshaw. The most interesting aspect to the test pods is that they will be made using disused shipping containers, making them both safe and environmentally friendly. On top of that, the labs will have staff from Clarity Mobile Venture, which is a joint operation between Clarity Labs and SG Blocks.

Commenting on the deal, SG Blocks CEO Paul Galvin stated that they are happy to be working with LAX in the quest to make air travel safe. He added that with COVID-19 becoming the new normal, accessibility of rapid testing was becoming essential. He added that the company was able to offer both services using its D-Tec testing pods, and Turnkey D-Tec. On his part, Grimshaw Chairman Andrew Whalley stated that the D-Tec system was flexible and allowed for a fully operational lab to be used at the exact locations where samples are needed.

The LAX deal deepens the market presence of SG Blocks Inc as a world-class leader in the development of use-of-code engineered shipping containers, that are safe to use and environmentally sustainable. This is likely to drive the demand for its products both now and in the long run.

One key aspect to the market that could see it record exponential growth is the ever-increasing challenge of the COVID-19 pandemic. Until a vaccine is found and widely deployed, testing remains one of the best ways to control the spread of the pandemic. In essence, with the LAX deal in position, the company is in pole position to land similar deals with other airports and company installations. This could see the company grow revenues grow to new heights in the near-term and see an increase in its stock price in the near-term. This makes it one of the high potential stocks to keep an eye on in the near-term.

About SG Blocks Inc

SG Blocks Inc is a container design and fabrications company. It is based in Brooklyn, New York.

September 25, 2020
Why Net Element Inc [NETE] is The Stock to Watch over the Next Decade

Net Element Inc [NASDAQ:NETE] is in breakout this afternoon. Though it is still volatile at the moment, today’s price move has seen it clear the losses from the last two months. The huge bullish reversal move follows the company’s announcement that Mullen, an electric car company that it recently announced a merger with was launching an electric car manufacturing facility.

The pilot facility is for the assembly of the MX-05, an electric SUV that will be completed in April next year. Mullen also announced that customers can start taking pre-orders for the SUV, and they would start at a price of $55k. The two companies recently merged in an all-stock deal that would see Mullen’s investors get the majority of the outstanding shares.

The deal is huge for Net Element investors because it means they stand to benefit from the huge value increase that will come with the sale of the MX-05. Mullen has already announced that it would start taking pre-orders for the SUV on 1^st October this year.

The company has also announced it would start the transformation of its California-based research and development facility into a state-of-the-art facility for the SUVs. The upgrade is expected to start in October as well. According to Mullen CEO David Michery, the company was happy to start the construction of the pilot facility and also start taking pre-orders for its electric SUV.

He added that the vehicles would be for homologation that that would take 16 months and get completed in May of 2022 when the company expects to start selling its first vehicle to the public.

Besides, the excitement that often comes with such news, Mullen’s plans for an electric SUV stands to benefit both Mullen and NETE element investors in the long run, and it stands to reflect in the stock price. That’s because the demand for EV’s stands to grow as governments continue to make favourable policies.

Yesterday, the Governor of California stated that the State intended to ban the sale of emitting cars by the year 2035. Automatically, this means that the demand for electric vehicles is set to keep growing over the next decade. Companies like Mullen that are already taking steps in this direction are likely to grow market share and revenues and peak as the ban on fossil fuel energy takes effect.

About Net Element Inc

Net Element Inc is a financial technologies company. It is headquartered in Miami Beach, Florida.

September 25, 2020
Two Reasons Why ClearOne Inc [CLRO] is a Perfect Buy at Current Prices

ClearOne Inc [NASDAQ:CLRO] has over the last few days 0recovered most of the losses from late August and the better part September. From a technical analysis perspective, the stock is at a price level where it can go in any direction. Ideally, the best entry point for this stock would be any price level above $3.

However, looking at it from a fundamentals perspective, its current price makes for a good entry price as well and has the potential for more gains. There are a number of factors that likely to drive up bullish sentiment in this stock in the near-term. Some of them are as below:

Insider buying

One of the biggest buy signals in the stock markets is insider buying. It usually points to a situation whereby people who have a close relationship with a company have faith in its growth prospects. A few days ago, ClearOne Inc announced that it had agreed with a group of institutional and accredited investors, Edward Bagley (It’s the largest shareholder), and its CEO Zeynep Hakimoglu for the purchase of 2,116,050 units of common stock at a price of $2.4925 per share.

In most cases, insider participation leads to an increase in stock as the fundamentals behind such a move start to unveil. In the case of ClearOne, it makes the stock’s current price a perfect entry point, for investors with both short-term and long-term projections for the stock.

It is also noteworthy that the company intends to use the proceeds of the sale to bolster its working capital. This means that in the near-term, the company is well-positioned to carry out its operations without the risk of running out of money. This is a critical factor that could see it gain in value going into the foreseeable future.

A patent win

Back in August, the company announced that the patent trial and appeal board of the U.S and the Trade Mark Office had ruled in its favor in a case against Shure. The company announced that the ruling significantly limited Shure’s 493 patent touching on beamforming microphone arrays.

This is a technology that was pioneered by ClearOne. The company stated that it believed its products do not infringe on Shure’s patent claims. This win is a big deal and is likely to have a significant impact on the company’s revenues in the long run, and by extension, its stock value. This further adds weight to this stock’s potential in the long run.

About ClearOne Inc

ClearOne Inc designs, makes, and sells networking solutions. It is based in Salt Lake City, Utah.

September 18, 2020
Scientific Games Corporation [SGMS] Rallies after the Entry of Strategic Investors

Scientific Games Corporation [NASDAQ: SGMS] is one of the biggest gainers this afternoon and is up by over 40%. This follows the company’s announcement that MacAndrews & Forbes were selling 34.9% in the company to a group of institutional investors.

They are selling the stake at $28 a share. On top of that, the company announced that it was reorganizing its board of directors in a move that would see the inclusion of Jamie Odell and Toni Korsanos as executive chairman and the executive vice-chairman respectively.

The excitement around this stock comes from the nature of the buyers for the MacAndrew & Forbes shares. The company announced that the stake was being sold to gambling industry investors that include Caledonia. This has a number of positive implications:

Expertise

By bringing in institutional investors that have expertise in gambling, the company can leverage this to grow its market share, and revenues. This could see investors keep bidding up the stock up in the near-term, in anticipation of a jump in price.

In the long run, the expertise and market experience of the institutional investors are likely to drive up the company’s intrinsic value. The company has already stated that it would use the deal to start the implementation of a transformative strategy that would see it grow shareholder value in the long run.

The capital to grow its market

The company has stated that part of its strategy is to focus on digital gaming, and sports betting. The company is aware that these lucrative markets are dominated by DraftKings and FanDuel. As such, it aims to take aggressive measures to penetrate this market.

This requires both money and social capital, and the company will benefit from the monetary and social capital of the institutional investors to get into this market. Given how lucrative the sports gaming market is, the company’s long term value stands to grow. In the short-term, the company also stands to benefit as investors take positions in anticipation of the company’s intrinsic value in the long run.

With all these factors at play, this stock is uniquely positioned to grow in value. Externally, the value of this stock could benefit from the discovery of a COVID-19 vaccine, as it would drive up the entire market. It would also lead to a jump in consumer spending, which is key to driving up consumption.

About Scientific Games Corporation

Scientific Games Corporation is a gaming technology company. It makes electronic gaming machines, and server gaming systems.

September 15, 2020
Why IBIO Inc [IBIO] is the Best Covid-19 Vaccine Stock to Bet On

IBIO Inc [NYSE: IBIO] is trading on a monthly support level, and it seems to be holding up quite well. One factor that could trigger a run in this stock is the discovery of a viable COVID-19 vaccine. Yesterday, the company announced that it had settled on its most viable COVID-19 vaccine.

The company announced that while it had two vaccine candidates named IBIO-200 and IBIO-201, it was going forward with IBIO-201. The company stated that both candidates did well in pre-clinical studies on the production of antibodies for fighting the virus.

However, it also discovered that IBIO-201 did better in terms of producing more antibodies than IBIO-200, making it a more viable candidate. Nonetheless, the company stated that it would continue pre-clinical development for IBIO-200 and see where it goes.

Commenting on these developments, CEO Tom Isett stated that the decision to observe the two vaccines together was beneficial as it helped the company to settle on IBIO-201 as the most viable candidate. He added that the company would now go ahead with the toxicology studies on this vaccine candidate and also conduct clinical development on the same. On IBIO-200^,the CEO stated that pre-clinical development would go on, and would use it as a potential plug-and-play vaccine system.

What next for IBIO

With the company’s vaccine candidate showing potential, the company is in a unique position in the race for a vaccine. That’s because timing will be critical for companies to profit from a COVID-19 vaccine. Companies that will be among the first to release a vaccine are likely to win the majority of the orders. So far, IBIO is among those in the lead for a vaccine.

A few days ago, the Oxford-led vaccine was paused due to adverse effects on some test subjects. This means that IBIO is still within the right timelines for potential COVID-19 vaccines. If it makes a breakthrough anytime soon, the stock could see an exponential surge in value.

There is also the fact that the company is small-cap compared to the much bigger companies that are working on a vaccine. This means that if the company’s vaccine is approved, it would have a much bigger leeway for growth compared to companies that already have large market caps. It also means that if it releases a vaccine at the same time as a large-cap, it would have a better chance of exponential gains.

About IBIO Inc

IBio is a biotech company that offers manufacturing services for clients and 3^rd party companies. It is based in New York, New York.

September 10, 2020
Intra-Cellular Therapies [ITCI] Rallies on positive news on depression treatment

The markets are up this afternoon after days in the red. Most stocks are up, and some like Intra-Cellular Therapies [NASDAQ: ITCI] are recording exponential gains. This stock is currently up by over 60% and gaining. This bullish breakout has seen the stock reverse all the losses it incurred over the past 3 months, and if it holds, could see the stock enter a new bull rally.

Today’s breakout comes after the company announced that it had got positive results from its study that was analyzing Lumateperone when used as adjunctive therapy in people suffering from bipolar depression. Delving into the details of the deal, the company stated that 42 mg of Lumeteperone had shown primary results that are statistically significant, and that it also met its secondary endpoints.

The company added that it was expecting to submit an SNDA (supplementary new drug application) for it to the FDA later this year or in early 2021. The company added that the study had returned an acceptable safety and tolerability profile that was fully in line with the company’s other trials on the treatment. The company further stated that all side effects including the rate of akathisia, changes in weight, extrapyramidal symptoms and restlessness were all the same as the placebo.

Commenting on the development, CEO Dr Sharon Mates stated that the program had confirmatory evidence of efficacy and that it had positive safety and tolerance in people with bipolar depression. He added that with the achievement of this clinical milestone, the treatment had the potential to improve the lives of people suffering from a wide array of mental health conditions, including schizophrenia.

What next?

With the progress that it has made with this treatment, the stock is well-positioned to grow in the near-term for several reasons. First, on the expectation of growth as the treatment gets closer to going to market, investors are likely to keep bidding up the stock. Secondly, the stock could see its value grow long-term if this treatment goes through the various steps and is approved by the FDA. That’s because it would significantly add to its bottom-line. This increase in intrinsic value would see the stock keep gaining in the near-term.

The stock also stands to gain from the increased upside momentum in the market. As markets rise, stocks with strong fundamentals stand to outperform the market.

About Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc is a biotech company that makes new treatments for neurological diseases. It is based in New York, New York.

September 9, 2020
Why Co-Diagnostics Inc (CODX) Stock Bullish Reversal Could Mark the Start of a New Uptrend

Its good day for Co-Diagnostics Inc [NASDAQ:CODX] investors. After several months in the red, the stock has rocketed today and is currently up by 31%. The rally follows the company’s announcement that it had made an agreement with Arches Research Inc for the expansion of Arche’s COVID-19 testing services. This will be implemented using Co-Diagnostics’ test kit called Logix Smart.

The deal is a continuation of a relationship that started earlier in the year when Arches Research began using the Co-Diagnostics kits for testing. The signing of the deal comes just days after a 3^rd party study on the kits concluded that their performance was good and that they could be used in smoothening out the process of reopening workplaces, schools, and other amenities.

Commenting on the agreement, Co-Diagnostics CEO Dwight Egan stated that they were happy with the expanded relationship with one of the company’s most valued lab clients. He added that they were optimistic that the expanded relationship would open new opportunities to sell not just test kits, but other diagnostic products that the company was working on. Some of the products that it has under development include the upcoming Logix Smart Flu A/ Flu B and COVID-19 kits.

What next?

With this deal in place, this stock’s current bullish reversal could mark the start of a new uptrend. That’s because, with the expanded deal, the company’s revenues will grow in coming quarters. This will mean a higher intrinsic value for the company and by extension its price. On top of that, investors anticipating stronger earnings in the near-term are likely to keep bidding up the stock price in the near-term. This is already happening as can be seen in the sustained increase in price since the company announced the expanded deal.

There is also the fact that with the 3^rd party validation of the company’s test kits, other companies and even governments are likely to start making their orders for its COVID-19 test kits. That’s because, while the world is awaiting a vaccine, testing remains the most effective way to fully get the economy working optimally again in the near-term. It is through testing that establishments that deal with lots of people can reopen safely, by isolating those who have COVID-19 from the rest of society. Testing also presents an opportunity for governments to understand the patterns of the disease and model it for policy decision-making on COVID-19.

About Co-Diagnostics Inc

Co-Diagnostics Inc is a molecular diagnostics corporation. It is based in Salt Lake, Utah.

September 8, 2020
Why PolyMet Mining Corp [PLM] is Rallying as Markets Correct

PolyMet Mining Corp [NYSE: PLM] is braving the market sell-off this afternoon and is up by over 70% at the time of writing. The stock’s momentum is driven by a confluence of positive factors around it. The latest of this news is with regards to the company’s clearance by a court in a case involving its adherence to procedure.

Yesterday, a judge in the Ramsey District Court ruled that the Minnesota Pollution Control Agency did not err in the procedure when it processed the National Pollutant Discharge Elimination System permit for a precious metals, copper and nickel project that is run by a subsidiary of PolyMet Mining Corp.

The judge rejected in totality allegations that the MPCA took steps to keep evidence from its administrative records. Commenting on the development, PolyMet President and CEO stated that the company was happy with the ruling of the District Court.

He added that the company was confident that the permit and applicable standards will be upheld by the courts. This is a big deal for the company as it looks forward to a favourable ruling on a Minnesota Supreme Court to give the company its permits on mining, air quality, and dam safety.

Oral arguments on the permits will be heard in October 2020. Given that this permits touch directly on the company’s operations, there is a good chance that it will lead to an increase in the company’s revenues. It is for this reason that investors are bidding up the price in anticipation of a price appreciation in the near-term.

The news comes just a few days after the company did a 1 to 10 reverse stock split. On the 26^th of August, 2020, the company announced that the split would drop the number of common shares from 1,006, 997, 495 to 100,699, 749 shares. The reverse share split has added to the stock’s momentum at the moment.

The above factors have also created FOMO around the stock as other stocks sink in the red. As investor chase gains and try to recover losses in other stocks, they could keep bidding up the stock and see it close the day as one of the top stock’s biggest in the week This coupled with the company’s fundamentals could see it start next week on a high note.

About PolyMet Mining Corp

PolyMet Mining Corp develops natural resources with a focus on precious metals and other minerals. It is headquartered in Toronto, Canada.

September 7, 2020